Hologic, Inc. provided preliminary revenue guidance for first fiscal quarter ended December 25, 2021. For the quarter, the company expects to report total revenues of approximately $1,471.1 million, a decrease of (8.6%) compared to the prior year period, or (8.2%) in constant currency. These preliminary results compare to the Company's most recent guidance range of $1,100 to $1,150 million, which was provided on November 1, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.07 USD | +1.19% |
|
+1.78% | +2.27% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.27% | 17.05B | |
+6.37% | 216B | |
+10.21% | 189B | |
+28.22% | 153B | |
+34.42% | 114B | |
+0.80% | 63.2B | |
+19.21% | 54.78B | |
+0.13% | 48.47B | |
-4.16% | 38.88B | |
+2.39% | 36.14B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic, Inc. Provides Preliminary Revenue Guidance for First Fiscal Quarter Ended December 25, 2021